Diabetes
Services
Our outpatient program consists of two tracks, either or both tracks may be used:Comprehensive Diabetes Management Track
This track is a team approach providing ongoing diabetes management which includes individualized health evaluations with a physician or nurse practitioner, certified diabetes nurse educator, and registered dietician functioning as a team along with your primary care physician. We realize that diabetes is a dynamic process and there may be times when more intensive support is indicated. Our program is designed to offer this flexibility based on changing diabetes care needs.
Diabetes Education Group
This track is maintained by our Certified Diabetes Educators and is meant to provide education and support. Changes to your diabetes management will not take place during these sessions. This program is a series of monthly education sessions conducted in a group format which meets on the last Tuesday of every month at 1:30-3:30 p.m. Groups are open to anyone in the community living with diabetes and their family members.
Other Services
Continuous Glucose Monitoring System
CGMS, a special glucose monitor, worn discreetly, has a sensor which is inserted just under the skin and measures blood sugar values every 5 minutes for up to 3 days. The CGMS provides detailed glycemic profiles used as a tool to design an individualized diabetes treatment program.
Insulin Pumps
Insulin pump therapy provides the tightest control for Type 1 diabetics. Pump therapy provides convenience and flexibility for those patients who do not want a rigid injection and meal schedule. However, insulin pumps are not appropriate for everyone and should be discussed with diabetes provider.
Inpatient Adult Diabetes Service
Clinical research has identified hyperglycemia as a factor that increases length of stay, hospital complications, and even inpatient mortality. This program is designed to meet current national standards for glycemic control in hospitalized patients. This includes patients with known diabetes, as well as those with newly identified hyperglycemia.
